Literature DB >> 33765316

A Mouse Model of Helicobacter pylori Infection.

Tanmoy Kumar Dey1, Bipul Chandra Karmakar1, Avijit Sarkar1, Sangita Paul1, Asish Kumar Mukhopadhyay2.   

Abstract

Infection with Helicobacter pylori (H. pylori) is of great distress because of its vital role in the pathogenesis of chronic gastritis, peptic ulcers, and in the multi-step carcinogenic process of gastric cancer. The increasing antibiotic resistance pattern of H. pylori worldwide has prompted the World Health Organization to put this organism in the priority pathogens list. To study the disease biology, evaluation of drugs, treatment outcome and to come up with probable vaccination strategies, competent animal models that reproduce the signature of human infection are essential. Initial reports about animal colonization with H. pylori have shown significant heterogeneity, to such an extent that Barry Marshall, Nobel laureate for the discovery of H. pylori , infected himself with the bacterium to show its involvement in acute gastric illness. A paradigm-shift discovery of the H. pylori mouse-adapted strain SS1 has opened the avenues of research regarding the organism and its pathogenicity. Although the mouse model of H. pylori infection is being utilized all over the world, there are certain issues that need awareness and specific information to achieve successful, consistent colonization with symptoms resembling human. This chapter details an established and reliable protocol for the development of a competent mouse model for H. pylori infection leading to various gastro-intestinal diseases.

Entities:  

Keywords:  C57BL/6 mice; Colonization; Gastric cancer; Gastric mucosa; Gastritis; Helicobacter pylori; Mouse model; Peptic ulcer; Urease

Mesh:

Substances:

Year:  2021        PMID: 33765316     DOI: 10.1007/978-1-0716-1302-3_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  49 in total

1.  Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy.

Authors:  S Datta; S Chattopadhyay; R Patra; R De; T Ramamurthy; J Hembram; A Chowdhury; S K Bhattacharya; D E Berg; G B Nair; A K Mukhopadhyay
Journal:  Aliment Pharmacol Ther       Date:  2005-07-01       Impact factor: 8.171

Review 2.  Antibiotic resistance in Helicobacter pylori.

Authors:  Claudio Alba; Ana Blanco; Teresa Alarcón
Journal:  Curr Opin Infect Dis       Date:  2017-10       Impact factor: 4.915

3.  Differences in genotypes of Helicobacter pylori from different human populations.

Authors:  D Kersulyte; A K Mukhopadhyay; B Velapatiño; W Su; Z Pan; C Garcia; V Hernandez; Y Valdez; R S Mistry; R H Gilman; Y Yuan; H Gao; T Alarcón; M López-Brea; G Balakrish Nair; A Chowdhury; S Datta; M Shirai; T Nakazawa; R Ally; I Segal; B C Wong; S K Lam; F O Olfat; T Borén; L Engstrand; O Torres; R Schneider; J E Thomas; S Czinn; D E Berg
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

4.  Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India.

Authors:  A K Mukhopadhyay; D Kersulyte; J Y Jeong; S Datta; Y Ito; A Chowdhury; S Chowdhury; A Santra; S K Bhattacharya; T Azuma; G B Nair; D E Berg
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

5.  Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

Authors:  B J Marshall; J R Warren
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

6.  Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA.

Authors:  Manuel R Amieva; Roger Vogelmann; Antonello Covacci; Lucy S Tompkins; W James Nelson; Stanley Falkow
Journal:  Science       Date:  2003-05-30       Impact factor: 47.728

7.  Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses.

Authors:  K Robinson; R Kenefeck; E L Pidgeon; S Shakib; S Patel; R J Polson; A M Zaitoun; J C Atherton
Journal:  Gut       Date:  2008-05-08       Impact factor: 23.059

8.  Helicobacter pylori strains harboring babA2 from Indian sub population are associated with increased virulence in ex vivo study.

Authors:  Prachetash Ghosh; Avijit Sarkar; Mou Ganguly; Jawed Alam; Ronita De; Asish K Mukhopadhyay
Journal:  Gut Pathog       Date:  2016-01-12       Impact factor: 4.181

Review 9.  Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.

Authors:  Yi Hu; Yin Zhu; Nong-Hua Lu
Journal:  Front Cell Infect Microbiol       Date:  2017-05-05       Impact factor: 5.293

Review 10.  Nature meets nurture: molecular genetics of gastric cancer.

Authors:  Anya N Milne; F Carneiro; C O'Morain; G J A Offerhaus
Journal:  Hum Genet       Date:  2009-08-06       Impact factor: 4.132

View more
  3 in total

Review 1.  Animal Models and Helicobacter pylori Infection.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

2.  Effect of Helicobacter pylori-Associated Chronic Gastritis on Autonomous Activity and Sleep Quality in Mice.

Authors:  Haihua Liu; Wenlong Zheng; Ling Zhang; Tangtang Lin; Yang Tang; Ling Hu
Journal:  Front Pharmacol       Date:  2022-02-04       Impact factor: 5.810

3.  Co-ingestion of glutamine and leucine synergistically promotes mTORC1 activation.

Authors:  Ryoji Yoshimura; Shuichi Nomura
Journal:  Sci Rep       Date:  2022-09-23       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.